MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Laryngeal squamous cell carcinoma (LSCC) is an aggressive cancer with high mortality.
• MicroRNAs (miRNAs) are key regulators of gene expression.
• Dysregulation of miRNAs is implicated in various cancers, including LSCC.

Purpose of the Study:

• To investigate the role of miR-300 in LSCC.
• To identify the target genes of miR-300 in LSCC.
• To explore the therapeutic potential of miR-300 in LSCC.

Main Methods:

• Quantitative real-time PCR to measure miR-300 and ROS1 expression.
• Cell proliferation assays (e.g., Ki-67, PCNA).
• Cell invasion assays.
• Western blotting to assess protein expression.
• Luciferase reporter assays to confirm direct targeting.

Main Results:

• miR-300 expression was significantly downregulated in LSCC tissues.
• Overexpression of miR-300 inhibited Hep-2 cell proliferation and invasion.
• ROS1 was identified as a direct target gene of miR-300.
• ROS1 expression was upregulated in LSCC tissues and inversely correlated with miR-300 levels.
• Overexpression of ROS1 promoted cell proliferation and invasion, and abrogated miR-300's inhibitory effects.

Conclusions:

• miR-300 functions as a tumor suppressor in LSCC.
• The miR-300/ROS1 axis plays a critical role in LSCC progression.
• Restoring miR-300 levels may offer a potential therapeutic strategy for LSCC.